Dexmedetomidine reduces in-hospital mortality in aneurysmal subarachnoid hemorrhage patients by modulating three key genes and inflammatory pathways: insights from clinical and bioinformatics analyses
BackgroundAneurysmal subarachnoid hemorrhage (aSAH) is a cerebrovascular disease with high mortality. Dexmedetomidine has a neuroprotective effect. This study aimed to explore the clinical and molecular association between dexmedetomidine and in-hospital mortality of aSAH.MethodsPatients with aSAH i...
Salvato in:
| Autori principali: | , , , |
|---|---|
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
Frontiers Media S.A.
2025-07-01
|
| Serie: | Frontiers in Neurology |
| Soggetti: | |
| Accesso online: | https://www.frontiersin.org/articles/10.3389/fneur.2025.1554809/full |
| Tags: |
Nessun Tag, puoi essere il primo ad aggiungerne!!
|